285 related articles for article (PubMed ID: 15583526)
21. Non-estrogen conventional and phytochemical treatments for vasomotor symptoms: what needs to be known for practice.
Villaseca P
Climacteric; 2012 Apr; 15(2):115-24. PubMed ID: 22148909
[TBL] [Abstract][Full Text] [Related]
22. Polymorphisms in the estrogen synthesis and metabolism pathways and symptoms during the menopausal transition: observations from the Seattle Midlife Women's Health Study.
Woods NF; Mitchell ES; Tao Y; Viernes HM; Stapleton PL; Farin FM
Menopause; 2006; 13(6):902-10. PubMed ID: 16977255
[TBL] [Abstract][Full Text] [Related]
23. Menopausal symptoms.
Morris E; Rymer J
Clin Evid; 2005 Jun; (13):2392-406. PubMed ID: 16135332
[No Abstract] [Full Text] [Related]
24. The menopausal hot flush--anything new?
Sturdee DW
Maturitas; 2008 May; 60(1):42-9. PubMed ID: 18384981
[TBL] [Abstract][Full Text] [Related]
25. The Herbal Alternatives for Menopause (HALT) Study: background and study design.
Newton KM; Reed SD; Grothaus L; Ehrlich K; Guiltinan J; Ludman E; Lacroix AZ
Maturitas; 2005 Oct; 52(2):134-46. PubMed ID: 16186076
[TBL] [Abstract][Full Text] [Related]
26. Undertreatment of menopausal symptoms and novel options for comprehensive management.
Lewis V
Curr Med Res Opin; 2009 Nov; 25(11):2689-98. PubMed ID: 19775194
[TBL] [Abstract][Full Text] [Related]
27. Effects of estrogen plus progestin on health-related quality of life.
Lopes AA; Latado A; Lopes GB
N Engl J Med; 2004 Feb; 350(6):622. PubMed ID: 14762196
[No Abstract] [Full Text] [Related]
28. The effects of combined raloxifene and oral estrogen on vasomotor symptoms and endometrial safety.
Stovall DW; Utian WH; Gass ML; Qu Y; Muram D; Wong M; Plouffe L
Menopause; 2007; 14(3 Pt 1):510-7. PubMed ID: 17314736
[TBL] [Abstract][Full Text] [Related]
29. Options for hormone therapy in women who have had a hysterectomy.
Haney AF; Wild RA
Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
[TBL] [Abstract][Full Text] [Related]
30. A randomized placebo-controlled trial on the effectiveness of an herbal formula to alleviate menopausal vasomotor symptoms.
van der Sluijs CP; Bensoussan A; Chang S; Baber R
Menopause; 2009; 16(2):336-44. PubMed ID: 19057416
[TBL] [Abstract][Full Text] [Related]
31. Estrogen with and without progestin: benefits and risks of short-term use.
LaCroix AZ
Am J Med; 2005 Dec; 118 Suppl 12B():79-87. PubMed ID: 16414331
[TBL] [Abstract][Full Text] [Related]
32. Non-hormonal therapy of post-menopausal vasomotor symptoms: a structured evidence-based review.
Cheema D; Coomarasamy A; El-Toukhy T
Arch Gynecol Obstet; 2007 Nov; 276(5):463-9. PubMed ID: 17593379
[TBL] [Abstract][Full Text] [Related]
33. Menopausal symptoms.
Morris E; Rymer J
Clin Evid; 2004 Jun; (11):2459-73. PubMed ID: 15652118
[No Abstract] [Full Text] [Related]
34. Menopausal symptoms.
Morris E; Rymer J
Clin Evid; 2003 Dec; (10):2138-50. PubMed ID: 15555195
[No Abstract] [Full Text] [Related]
35. Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626.
Goodwin JW; Green SJ; Moinpour CM; Bearden JD; Giguere JK; Jiang CS; Lippman SM; Martino S; Albain KS
J Clin Oncol; 2008 Apr; 26(10):1650-6. PubMed ID: 18375894
[TBL] [Abstract][Full Text] [Related]
36. Isoflavone treatment for acute menopausal symptoms.
Cheng G; Wilczek B; Warner M; Gustafsson JA; Landgren BM
Menopause; 2007; 14(3 Pt 1):468-73. PubMed ID: 17290160
[TBL] [Abstract][Full Text] [Related]
37. Duration of vasomotor symptoms in middle-aged women: a longitudinal study.
Col NF; Guthrie JR; Politi M; Dennerstein L
Menopause; 2009; 16(3):453-7. PubMed ID: 19188852
[TBL] [Abstract][Full Text] [Related]
38. Cimicifuga racemosa dried ethanolic extract in menopausal disorders: a double-blind placebo-controlled clinical trial.
Frei-Kleiner S; Schaffner W; Rahlfs VW; Bodmer Ch; Birkhäuser M
Maturitas; 2005 Aug; 51(4):397-404. PubMed ID: 16039414
[TBL] [Abstract][Full Text] [Related]
39. Estradiol gel 0.1% relieves vasomotor symptoms independent of age, ovarian status, or uterine status.
Hedrick RE; Ackerman RT; Koltun WD; Halvorsen MB
Menopause; 2010; 17(6):1167-73. PubMed ID: 20720511
[TBL] [Abstract][Full Text] [Related]
40. [Phytoestrogens--an alternative to hormonal replacement therapy].
Drosdzol A; Skrzypulec V; Nowosielski K; Piela B; Rozmus-Warcholińska W; Walaszek A
Wiad Lek; 2004; 57 Suppl 1():74-7. PubMed ID: 15884209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
